In eye clinics and clinical trials, doctors increasingly rely on patients' own reports of how eye disease and treatment ...

Diabetic retinopathy (DR) is a common chronic complication of diabetes mellitus. Endothelin-1 (ET-1) has been identified as a key regulator of various ocular functions, including vascular perfusion, ...

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

Individuals with type 2 diabetes — with or without retinopathy — had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with ...

Abstract: Diabetic Retinopathy (DR) is a serious complication of diabetes and a major cause of vision loss. The damage it causes to the retina is permanent, which makes early detection and accurate ...

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...

Quadrant-specific changes in superficial vascular complex vessel density, particularly in the 16- to 21-mm temporal region, are potential early biomarkers for diabetic retinopathy. Widefield ...

In research published in the journal Gut, investigators from the University of Alabama at Birmingham report that restoring tryptophan metabolism in the gut microbiome can prevent or reverse diabetic ...

A higher incidence of new diabetic retinopathy has previously been reported in patients using GLP-1 receptor agonists. A new retrospective study suggested that use of tirzepatide was tied to a reduced ...

Type 2 diabetes mellitus (T2DM) constitutes a rapidly expanding global epidemic whose societal burden is amplified by deep-rooted health inequities. Socio-economic disadvantage, minority ethnicity, ...